NVP-BEZ235 targets PI3K and mTOR equally in cancer [25], and we postulated that the combination of a PI3K/mTOR inhibitor and an HSP90 inhibitor might cooperatively inhibit tumor cell proliferation and induce apoptosis. The gene discussed is MTOR; the disease is cancer.